Scipio bioscience teamed up with Dr. Eric Villard from the Research Unit on Cardiovascular and Metabolic Diseases at the Pierre and Marie Curie School of Medicine, Paris, France, to study the generation of human cardiomyocytes from human induced pluripotent stem cells (hiPSC) to improve the in vitro models of heart disease.

The current poster was presented at the 2023 Annual meeting of the European Society of Cardiology Working Group on Development, Anatomy and Pathology (DAP).